Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

McCormick Reaffirms FY24 Sales Growth Outlook Of (2)% - 0%; Adj EPS Of $2.80 - $2.85 Vs. $2.83 Est.

Author: Benzinga Newsdesk | March 26, 2024 06:35am

Posted In: MCK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist